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The present paper is a report by the Subcommittee for the Study of Endemic 
Goiter and Iodine Deficiency of The European Thyroid Association ( E T A ) . I 
am grateful for the Cooperation of the 10 other members of the subcommittee 
and to many other contributors listed*. 
* Members of the E T A subcommittee: P.C. SCRIBA, Lübeck (chairman); C. B E C K E R S , 
Bruxelles; H. BÜRGI, Solothurn; F. E S C O B A R D E L R E Y , Madrid; M . GEMBICKI, 
Poznan; D.A. K O U T R A S , Athens; B.A. L A M B E R G , Helsinki; P. L A N G E R , Bratislava; 
E. Q U E R I D O , Leiden, C. T H I L L Y , Bruxelles; R. VIGNERI, Catania. 
Further contributors: The ETA-subcommittee is grateful for personal communication of un-
published informazion and references cited as received from: N. C A B A S S A , Bolzano; A. COS-
T A , Torino; F. D E L A N G E , Bruxelles; E . D Ü R E N , Instanbul; J.W. F. E L T E , Leiden; G. 
FENZI, Pisa; H. FREY, Oslo; G . G A L V A N , Salzburg; R. G O E B E L , Graz, B. M . GOSLING, 
Leiden; R. G U T E K U N S T , Lübeck; G. H E N N E M A N N , Rotterdam; F.A. HORSTER, Düssel-
dorf; R. I S L A M B E K O V , Moscow; M . H . J O N C K E E R , Bruxelles; P. L A M P E R T I C O , Milano; 
P. L A U R B E R G , Arhus; J. L A Z A R U S , Cardiff; E . LIMBERT, Lisboa; W. M E N G , Greifswald; 
S. M. M I L C U , Bucuresti; T. M U N K E R , Kopenhagen; F. PETER, Budapest; A . PINCHERA, 
Pisa; J. PODOBA, Bratislava; G. R I C C A B O N A , Innsbruck; B. SELZ, Solothurn; K.M. 
SJÖBERG, Osskarhamn; P. S M Y T H , Dublin, L . G . SOBRINHO, Lisboa; G. SZILAGYI, 
Budapest; Z. SZYBINSKI, Krakow; I. U R G A N C I O G L O U , Istanbul; D. van der HEIDE, 
Leiden; W. W A L D H Ä U S L , Wien. 
This subcommittee was established in the late seventies by Dr . A . Querido. 
After two preliminary reports to the E T A in Pisa (1981) and Brüssels (1982) 
the final report of the committee is due to be presented at the forthcoming 
ETA-Meet ing in Rotterdam, September 1984. It is hoped that the E T A 
committee will not object to my disclosing some of the information already 
available in advance. 
In general, epidemiologic information in a strict sense is scanty in most 
European countries. There is much regional data available with relatively good 
information concerning the population sample studied as for age and sex. 
However it is frequently difficult to conclude which part of the whole popula-
tion of a given area is represented by the sample studied, and what percentage 
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of the total inhabitants of a country live in the area studied. The techniques for 
the study of endemic goiter (8) as recommended by W H O and P A H O (Pan 
American Health Organization) have not been fully applied. Despite the 
limitations of these studies the currently available information is still consid-
erable. 
In 1937, H . Pflüger published two maps depicting the goiter distribution in 
Central Europe, one of his own and one drawn by H . Bircher in 1883. D . A . 
Koutras (16) and P. Langer (20) and others reviewed the Situation in Europe 
up to the late seventies in the book by J .B. Stanbury and B.S. Hetzel on 
Endemic Goiter and Endemic Cretinism (28). The data collected by the 




[ ] denotes regional values 
FIG. 1. Goiter Prevalence in Europe, Preliminary Map of the European Thyroid Associaio>n. 
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REVIEW 
The review of the Situation in the individual European countries is necessari-
ly incomplete and will be focussed on some points of general interest. 
1. Endemic goiter in the country as a whole 
The Federal Republic of Germany has an average goiter prevalence of 15% 
asobserved in 5.4 million recruits and published in 1975 by Horster et a l . (15) 
with 85% of the goitrous having stage I goiters. The mean iodine excretion was 
20 [xg/g Creatinine in the south and 35 in the north as determined by Haber-
mann e t a l . 1975 (16) in approximately 2000 school children and in more than 
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5000 adults from all over the country. There have been several more recent 
reports confirming the ongoing iodine deficiency. The goiter incidence may be 
even higher as demonstrated by Gutekunst et a l . (12), using the technique of 
Sonographie volumetry. 
Likewise, goiter endemia and iodine deficiency in the country as a whole 
were well documented by Menger a l . (22) for the German Democratic Repub-
lic. 
The available information permits to assume, but not to prove that ubiquit-
ous endemic goiter and iodine deficiency still exist in the following countries: 
Poland, Hungary, Romania, and Bulgaria, some of which have definitely 
improved the Situation. 
2. Former iodine deficiency 
A number of countries have convincingly shown that there is either no 
goitre, or that endemic goiter has been eliminated. This applies to Norway, 
Sweden, Finland and probably Denmark. 
For Norway, Frey et a l . (11) reported that the urinary iodine excretion varies 
in women and men between 165-364 [ig per day. The high iodine intake is 
mainly due to the feeding of cows with seaweed, whereas iodized salt which 
contains only 5 \ig K I per kg, contributes only negiigible amounts of iodine. 
Sweden has gradually increased the iodine content of table salt for mandat-
ory use up to 50 mg per kg. The Situation in Finland will be dealt with by A . 
Lamberg (18, 19), who reported that the average dietary iodine intake is now 
340 [ig per day, so that the brackets in the figure 2 may be eliminated. 
In Denmark a study by Munkner (23) of 6000 young men from all over the 
country showed that the population lives at a marginally low rate of iodine 
excretion of 41-68 |ig/day in Jutland and 68-139 [xg/day in Seeland. However 
no endemic goiter was detected in more than 350,000 children aged 7 to 17 
years. The same contrasting Observation of borderline iodine deficiency with-
outh proven endemic goiter was reported in Belgium by Beckers and Delange 
(3) and many others. 
3. Regional iodine deficiency and goiter 
A vast amount of information about the regional prevalence of endemic 
goiter, of iodine deficiency and sometimes even of cretinism was reported from 
almost all other European countries. 
There is still some regional endemic goiter left in the eastern parts of the 
Netherlands. The most recent survey communicated personally by Elte, van 
der Heide, Goslings and Querido indicated that 26% of female school children 
in Doetichem have goiters of grade O B . 
Most of the population of Portugal lives near the coast, where there is no 
endemic goiter (Sobrinho and Limbert, personal communication). However, 
several regions of the interior are severely affected. In one region of the district 
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of Castelo Branco nearly 16,000 school children and adults were studied in the 
early 60s. Prophylaxis with iodized salt (20 mg K I per kg) was started in 1971 
and reducedthe goiter prevalence from 51% to9.3% by 1977 (21). In another 
region, also in the district of Castelo Branco, the prevalence of goiter in school 
children approached 40%. Here the mean urinary iodine from school children 
lacking iodine Prophylaxis was only 12 ug/g Creatinine. Two further regions, 
Baixo Alentejo and Algarve and Portalagre, were recently shown to house 
goiter endemia up to 54% locally and also some endemic cretinism! 
There is insufficient space to discuss the information provided recently by 
Escobar del Rey (10) in detail. The Situation in adjacent Spanish provinces is 
not yet shown in fig. 1 and 2 and is comparable to that shown for Portugal. 
Ongoing studies in Spain revealed other regions of endemic goiter and iodine 
deficiency in Guadalajara, Cataluna and in Galicia. 
As for Italy it is impossible to review in this context the vast number of 
detailed studies published by Italian authors; some of them are pioneers in the 
field. Detailed surveys exist for the Valle D ' Aosta by Costa, for the Al to Adige 
by Cabassa, for Tuscany by Fenzi and Pinchera, and for Sicily by Vigneri, to 
name but a few. The picture may be summarized in that some densely popu-
lated areas are apparently free of endemic goiter, whereas regionally severe 
goiter endemias and iodine deficiency were shown particularly in the mountain 
districts (1, 2, 4, 5, 6, 7, 27, 30). 
The Situation in Greece was studied by Koutrasef a l . (17), and the Situation 
in Turkey resembles that in Italy (29). With regard to central Europe we have 
to mention Switzerland and the CSSR, where there are remnants of endemic 
goiter particularly in the older age groups (9). As for the CSSR, Podoba and 
Langer on the basis of excellent surveys coverning 2% of the whole population 
reported that endemic goiter is decreasing below 10% and that iodine excre-
tion was successfully raised to 100 ug/g Creatinine and will be raised further 
(20, 25). 
Further important nations not yet mentioned will be dealt with in the 
forthcoming ETA-Repor t . 
4. Iodine Prophylaxis 
The mandatory Prophylaxis in Sweden and the contribution by the iodine 
content of milk in Norway and in Finland has already been mentioned. In the 
Netherlands all salt used for baking bread has to be iodized. The report of the 
Ministry of Health published in 1981 and forwarded by G . Hennemann, 
proposed "that Struma Prophylaxis be improved by raising the K I content of 
bread and salt, so that one slice of bread would contain 20 \ig iodine. It also 
proposes making the addition of K I to household salt compulsory, so that 1 g 
salt would contain 20 \ig iodine". 
In Switzerland, the potassium iodide content of salt was raised from 5 to 10 
mg/kg in 1962 and to 20 mg/kg in 1980. The high goiter prevalence in the 
elderly is probably due to the fact that they suffered from iodine deficiency 
12 I O D I N E D E F I C I E N C Y I N E U R O P E 
before the salt was adequately iodinated (9). Further countries considering an 
increase in the iodine content of their salt are Austria, CSSR, Hungary, Poland 
and The Netherlands. 
It has been shown by Habermann et a l . (13) that potassium iodide was not 
sufficiently stable in iodized salt from several European countries. Therefore 
in the Federal Republic of Germany the iodination of salt to be used on a 
voluntary basis was altered in 1981, so that potassium iodate is added to give 
an iodine content of 20 mg per kg salt. 
CONCLUSIONS 
Bearing in mind the limitations of this review, due largely to the incomplete-
ness of information obtained, the results of the inquiries performed by the 
E T A subcommittee for the study of endemic goiter and iodine intake in 
Europe allow some conclusions to be made: 
1. There are some European countries where either endemic goiter used to 
be prevalent within the country as a whole, or where areas of endemic goiter 
(and cretinism) were formerly well described. Iodine Prophylaxis either man-
datory or voluntary, but accepted by more than 90% of the population was 
introduced in these countries but had and stili has to be intensified in some 
cases, since it was shown to be formerly insufficient. Nevertheless, eradication 
of endemic cretinism and a marked reduction of goiter prevalence have been 
reported particularly for the younger age groups. This description would 
probably apply to Austria (?), Bulgaria, Switzerland, CSSR, Hungary (?), The 
Netherlands (?), and Finland. 
Other countries with sufficient iodine intake and probably no endemic 
goiter are Great Britain (?), Ireland (?), Norway, and Sweden. A third group of 
countries have documented borderline low or insufficient alimentary iodine 
intake but fail to report even regional endemic goiter as in Denmark and 
Belgium (?). 
It is notable that the eradication of goiter has not only been achieved 
through iodine Prophylaxis but in some countries is also due to a change in 
dietary habits, e.g. feeding of seaweed to cows and use of iodine containing 
disinfectants in dairy hygiene. This resembles the Situation seen in the United 
States and in Tasmania. 
In the group of previously iodine deficient countries, some questions and 
continuing tasks remain including: 
— monitoring of iodine Prophylaxis, which needs to be continued with 
repetition of goiter prevalence surveys and monitoring of the urinary iodine 
excretion, 
— studies on prevalence of residual goiter and goitrogenic mechanisms 
other than iodine deficiency, and 
— longitudinal studies on the question, whether the sequelae of iodine 
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deficiency and endemic goiter, as nodular goiter in the eider age groups, or 
increased frequency of single toxic autonomous adenomas and disseminated 
autonomy will gradually subside. 
A l l efforts aimed at these problems have to be recommended for this group 
of countries. 
2. There are some European countries where endemic goiter is still preval-
ent, when the country is regarded as a whole. The two parts of Germany, 
Federal Republic of Germany and German Democratic Republic, have con-
vincingly demonstrated endemic goiter and iodine deficiency. Other countries 
may have to be added. A n effective general iodine Prophylaxis is recom-
mended strongly for these countries. 
3. There are some European countries, where only regional prevalence of 
endemic goiter and iodine deficiency have been documented, the remainder of 
the country being free of endemic goiter. The information reeeived up to now 
does not always allow conclusions as to the epidemiological Situation within 
the country as a whole. Therefore either general iodine Prophylaxis or regional 
measures are an alternative for these countries. The list of such countries may 
have to include Spain, France, Greece, Italy, Portugal, Poland (?), Romania, 
Turkey, and Yugoslavia. Possibly, one will have to add some of the following 
countries: Belgium, Denmark (?), Great Britain (?), Ireland (?), and the 
Soviet Union (?). 
Further epidemiological studies are strongly recommended for some of 
these countries, since either general or regional iodine Prophylaxis appears 
desirable. 
This short review may be adequately summarized by quoting Dr. A . 
Ouerido, Pisa (1981): 'The scientific Community of the E T A has the Obliga-
tion to contribute to the eradication of endemic goiter and iodine deficiency in 
Europe. With the available knowledge it seems an anachronism that endemic 
goiter in Europe still prevailes". 
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